The U.S. Food and Drug Administration (FDA) has reportedly taken action against an Austin-based company involved in the production of “poppers,” a popular inhalant drug linked with clubbing and homosexual activities. Double Scorpio, the company in question, stated on its website that it ceased operations after the FDA executed a search and seizure at its offices. This follows Robert F. Kennedy Jr.’s recent appointment as head of the U.S. Department of Health and Human Services (HHS), which supervises the FDA.
The FDA has not confirmed the specifics surrounding its actions or responded to inquiries about potential investigations involving popper manufacturers. Meanwhile, a spokesman for the agency emphasized the FDA does not comment on potential criminal investigations.
Another poppers company based in Buffalo, New York, named The Popper King, has indicated that the FDA has not contacted it concerning this issue. The substance in question, alkyl nitrates, offers a short-lived euphoric effect and muscle relaxation when inhaled. Increasing health impacts are being observed as a broader demographic beyond the gay community is now consuming poppers.
While Congress has attempted to regulate poppers, they continue to occupy a legal gray area, often marketed as commercial products like air fresheners to circumvent restrictions. In 2021, the FDA issued a warning to consumers citing severe health risks, including death, linked to popper use.
Joseph J. Palamar, a researcher at NYU Langone Health, has noted an uptick in popper-related health incidents, relying on data gathered from nightclub surveys. A recent study found that a lack of awareness among store employees may contribute to misuse.
Researchers suggest misinformation regarding dosage and habitual use could lead to dangerous consumption practices.
